Pro Medicus revenue at $162m as gross margin holds near 100%

The balance sheet carries no net debt. Cash holdings exceed borrowings by $153 million, and the debt-to-equity ratio is 1.1%. Return on equity reached 50.7% in fiscal 2024, meaning the company generated roughly 51 cents of profit for every dollar of shareholder equity.

Those figures frame the business quality. Revenue has compounded steadily. Margins reflect pricing power in a niche software market. Leverage is negligible.

The valuation question is separate. A company compounding profit at nearly 40% annually with a 99.8% gross margin commands a premium. Whether the current share price leaves room for error depends on the growth rate the market has already priced in. The operating numbers only tell one side of that story.